MG
EW icon

Mather Group’s Edwards Lifesciences EW Stock Holding History

Mather Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$408K Sell
5,097
-81
-2% -$6.68K ﹤0.01% 547
2025
Q4 		$441K Buy
5,178
+186
+4% +$15.3K ﹤0.01% 438
2025
Q3 		$388K Buy
4,992
+4
+0.1% +$313 ﹤0.01% 452
2025
Q2 		$390K Buy
4,988
+846
+20% +$63.1K ﹤0.01% 435
2025
Q1 		$300K Buy
4,142
+450
+12% +$32.2K ﹤0.01% 486
2024
Q4 		$273K Buy
3,692
+231
+7% +$16.2K ﹤0.01% 482
2024
Q3 		$228K Sell
3,461
-1,609
-32% -$117K ﹤0.01% 532
2024
Q2 		$484K Buy
5,070
+1,811
+56% +$160K 0.01% 423
2024
Q1 		$248K Sell
3,259
-1,769
-35% -$149K ﹤0.01% 480
2023
Q4 		$383K Sell
5,028
-395
-7% -$27.5K 0.01% 397
2023
Q3 		$376K Buy
5,423
+374
+7% +$30.1K 0.01% 387
2023
Q2 		$476K Buy
+5,049
New +$439K 0.01% 357
2022
Q4 		– Sell
-4,865
Closed -$402K – 488
2022
Q3 		$402K Buy
+4,865
New +$468K 0.01% 317
2022
Q2 		– Sell
-7,182
Closed -$846K – 412
2022
Q1 		$846K Buy
+7,182
New +$806K 0.02% 194

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Mather Group's EW Position: Q1 2026 in Review

Mather Group reduced its Edwards Lifesciences (EW) stake by 1.6% in Q1 2026, selling an estimated $6.68K and leaving 5,097 shares worth $408K. The position accounts for ﹤0.01% of the portfolio, ranked #547.

Mather Group first reported a position in EW in Q1 2022 and has held it in 14 quarters since. The position peaked at $846K in Q1 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Mather Group held 5,097 shares of Edwards Lifesciences worth $408K as of Q1 2026.
  • Mather Group sold 81 Edwards Lifesciences shares in Q1 2026, an estimated $6.68K.
  • Edwards Lifesciences made up ﹤0.01% of Mather Group's portfolio in Q1 2026, its #547 holding.
  • Mather Group first reported a position in Edwards Lifesciences in Q1 2022 and has held it in 14 quarters since.
  • Mather Group's Edwards Lifesciences position peaked at $846K in Q1 2022.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.